Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05209568 · ClinicalTrials.gov registry record · NA
Immune Responses to Gluten
A NA study of Celiac Disease and Gastrointestinal Diseases, sponsored by Boston Children's Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 400
- Enrollment target
- 2
- Study locations
NCT05209568 is a NA study of Celiac Disease and Gastrointestinal Diseases that is actively recruiting participants, run by Boston Children's Hospital. The registered enrollment target is 400 participants, below the 1,963-participant average among 24 other Celiac Disease trials with a reported enrollment target (80% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT05209568, a NA study of Celiac Disease and Gastrointestinal Diseases, is actively recruiting participants, sponsored by Boston Children's Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 400 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a study of immune responses after eating gluten powder in people with celiac disease and healthy controls.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Gluten Powder
Study Locations (2)
Colorado
- Children's Hospital Colorado - Aurora
Massachusetts
- Boston Children's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2023-01-15 |
| Est. Completion | 2029-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05209568
The ClinicalTrials.gov registry entry for NCT05209568 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,963-participant average among 24 other Celiac Disease trials with a reported enrollment target (80% lower). The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.
The record links to 7 conditions, with Celiac Disease appearing as the primary indexed condition, and to 1 intervention - of which Gluten Powder is the first listed.
NCT05209568 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Colorado, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05209568 about?
NCT05209568 is a clinical study titled "Immune Responses to Gluten". This is a study of immune responses after eating gluten powder in people with celiac disease and healthy controls.
What is the current status of trial NCT05209568?
This trial is currently recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2023-01-15. Estimated completion is 2029-09-30.
What conditions does trial NCT05209568 study?
This clinical trial studies the following conditions: Celiac Disease, Gastrointestinal Diseases, Digestive System Disease, Intestinal Disease, Celiac Disease in Children.
What interventions are being tested in trial NCT05209568?
The interventions under investigation include: Gluten Powder (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05209568?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05209568 being conducted?
This trial has 2 study locations across Colorado, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Celiac Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Tissue Destruction and Healing in Celiac Disease
RECRUITING · NA
-
Gluten Technology and Education for Celiac Health
RECRUITING · NA
-
T Cell Receptor (TCR) Sequencing and Transcriptional Profiling in Adult Celiac Disease Patients Undergoing Gluten Challenge
COMPLETED · NA
-
Validation of CapsoVision CapsoCam® SV-3 Capsule Endoscopy System
COMPLETED · NA
-
Changes in Intestinal Permeability 4 Hours After Gluten Challenge
COMPLETED · NA
-
Celiac Disease Genomic Environmental Microbiome and Metabolomic Study
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.